PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
PVCT was delisted on the 13th of October, 2016.
7 hedge funds and large institutions have $16K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
0% more capital invested
Capital invested by funds: $16K → $16K ($0)
13% less funds holding
Funds holding: 8 → 7 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HFBOT
1
Home Federal Bank of Tennessee
Knoxville,
Tennessee
| $7K | – | – | – |
|
|
LDB
2
Lee, Danner & Bass
Nashville,
Tennessee
| $3K | – | – | – |
|
3
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $2K | – | – | – |
|
|
CCB
4
Cutter & Co Brokerage
Ballwin,
Missouri
| $2K | – | – | – |
|
|
ACM
5
Academy Capital Management
Waco,
Texas
| $1K | – | – | – |
|
|
AA
6
Ancora Advisors
Cleveland,
Ohio
| $1K | – | – | – |
|
PVCT Hedge Fund Activity: Q2 2021 in Review
7 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q2 2021, worth a combined $16K — unchanged from a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PVCT and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
- 7 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q2 2021, down from 8 in Q1 2021.
- Funds reported $16K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q2 2021, unchanged quarter-over-quarter.
- 0 funds opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q2 2021 and 1 closed out, a net change of -1 holder.
Based on aggregated 13F filings for Q2 2021.